Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Badin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Value in Health Regional Issues|June 23, 2026
Artificial Intelligence in Health Technology Assessment Submissions: A Targeted Review of Global Policy and PracticeNishu Gaind, Matthew Badin, Johanna Jacob, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Bleeding risks for uncharacterized platelet function disordersJustin Brunet, Matthew Badin, Michael Chong, et al.
CJC Open|March 2, 2026
Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in CanadaJason Weatherald, Steeve Provencher, Jillian Murray, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Value in Health Regional Issues|June 23, 2026
Artificial Intelligence in Health Technology Assessment Submissions: A Targeted Review of Global Policy and PracticeNishu Gaind, Matthew Badin, Johanna Jacob, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Bleeding risks for uncharacterized platelet function disordersJustin Brunet, Matthew Badin, Michael Chong, et al.
CJC Open|March 2, 2026
Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in CanadaJason Weatherald, Steeve Provencher, Jillian Murray, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Pageof 1